Skip to main content
L&C BIO Co., Ltd logo

L&C BIO Co., Ltd — Investor Relations & Filings

Ticker · 290650 ISIN · KR7290650001 KO Manufacturing
Open in API
Filings indexed 378 across all filing types
Latest filing 2026-05-15 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 290650

About L&C BIO Co., Ltd

http://www.lncbio.co.kr/?locale=en_US

L&C BIO Co., Ltd. is a biotechnology company specializing in regenerative medicine. The company develops, manufactures, and commercializes human tissue-based medical devices and allograft treatment materials. Its core operations include the processing, storage, and distribution of human tissues, with a focus on skin, musculoskeletal, and soft tissues, utilizing patented processing technologies. The company's product portfolio also extends to other medical devices and cosmetics. L&C BIO supports its activities through dedicated research and development centers and manufacturing facilities, including a human tissue plant and a pharmaceutical plant, to advance its pipeline and serve global markets.

Recent filings

Filing Released Lang Actions
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 95% confidence The document is titled “분기보고서” (Quarterly Report) for the period January 1, 2026 to March 31, 2026, submitted to the Korean Financial Services Commission and Korea Exchange. It contains full financial statements, notes, management discussion & analysis, auditor’s opinion, corporate and governance information typical of a comprehensive interim/quarterly report. Therefore, it matches the definition of an Interim / Quarterly Report. Q1 2026
2026-05-15 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Classification · 85% confidence The document is a condensed announcement of provisional consolidated financial results for Q1 2026, including key P&L metrics (sales, operating profit, net profit) and comparisons to prior periods, with a disclaimer that these figures are unaudited provisional results (“잠정실적”). It is under 5,000 characters and provides the financial data itself rather than linking to a full report. This matches the definition of an Earnings Release (initial announcement of quarterly/periodical financial results). Q1 2026
2026-05-11 Korean
영업(잠정)실적(공정공시)
Earnings Release Classification · 97% confidence The document is a timely disclosure of preliminary quarterly (2026 Q1) operating results with key metrics (sales, operating profit, net income) compared to prior periods, notes that figures are provisional (잠정) and will be updated after audit, and provides contact and distribution details. This matches a standard Earnings Release (initial announcement of periodical financial results). It is not a full interim report (no detailed financial statements) nor merely a publication notice. Therefore, it is classified as an Earnings Release (ER). Q1 2026
2026-05-11 Korean
주식등의대량보유상황보고서(일반)
Regulatory Filings
2026-04-30 Korean
전환청구권행사
Share Issue/Capital Change Classification · 91% confidence The document is a public disclosure by L&C Bio regarding the exercise of conversion rights on its outstanding convertible bonds, detailing the number of new shares to be issued, conversion price, bond series, and remaining bond balance. This constitutes an issuance of new shares as part of a capital structure change. Therefore, it fits the 'Share Issue/Capital Change' category (SHA).
2026-04-23 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 95% confidence The document is a “주식등의 대량보유상황보고서(일반)” filed under Korean capital markets law (자본시장과 금융투자업에 관한 법률 제147조) reporting a large shareholder’s holdings and changes, including percentages and related party tables. It is a notification of significant share ownership and changes thereto, matching the definition of Major Shareholding Notification (MRQ). It is not an annual or interim report, earnings release, or other category.
2026-04-16 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.